Clopidogrel resistance [1]

Catheterization and Cardiovascular Interventions

Volumn 63, Issue 3, 2004, Pages 397-398

  Heptinstall, Stan ^a   Glenn, Jackie R ^a   May, Jane A ^a   Storey, Robert F ^a   Wilcox, Robert G ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; CLOPIDOGREL; ANTITHROMBOCYTIC AGENT; DRUG DERIVATIVE; TICLOPIDINE;

ANTICOAGULATION; CONCENTRATION RESPONSE; DRUG RESISTANCE; HUMAN; LETTER; NORMAL HUMAN; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; DRUG EFFECT; NOTE; PHYSIOLOGY; UNSTABLE ANGINA PECTORIS;

ANGINA, UNSTABLE; DRUG RESISTANCE; HUMANS; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; TICLOPIDINE;

EID: 8544250577     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.20165     Document Type: Letter

References (3)

1. Soffer D, Moussa I, Harjai KJ, Boura JA, Dixon SR, Grines CL, O'Neill WW, Roubin GS, Moses JW. Impact of angina class on inhibition of platelet aggregation following clopidogrel loading in patients undergoing coronary intervention: do we need more aggressive dosing regimens in unstable angina? Catheter Cardiovasc Interv 2003;59:21-25.
2. Fox SC, Burgess-Wilson M, Heptinstall S, Mitchell JRA. Platelet aggregation in whole blood determined using the Ultra-Flo 100 whole blood platelet counter. Thromb Haemost 1982;48: 327-329.
3. Storey RF, May JA, Wilcox RG, Heptinstall S. A whole blood assay of inhibition of platelet aggregation by glycoprotein IIb/IIIa antagonists: comparison with other aggregation methodologies. Thromb Haemost 1999;82:1307-1311.